Krystal Biotech
KRYS
KRYS
148 hedge funds and large institutions have $1.45B invested in Krystal Biotech in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 60 increasing their positions, 41 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.06% more ownership
Funds ownership: 81.07% → 81.12% (+0.06%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
53% less call options, than puts
Call options by funds: $5.09M | Put options by funds: $10.9M
Holders
148
Holding in Top 10
5
Calls
$5.09M
Puts
$10.9M
Top Buyers
| 1 | +$19.3M | |
| 2 | +$13.9M | |
| 3 | +$12.2M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$6.58M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.78M |
Top Sellers
| 1 | -$26.9M | |
| 2 | -$22M | |
| 3 | -$9.48M | |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$7.18M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$5.37M |